Código QR (código de barras bidimensional)

Therapeutic management of hyperlipoproteinemia (a)

Cardiovascular disease (CVD) has consistently been the leading cause of death worldwide. Several clinical and epidemiological studies have demonstrated that an elevated plasma concentration of lipoprotein (a) [Lp(a)] is a causative and independent major risk factor for the development of CVD, as wel...

ver descrição completa

Na minha lista:
Principais autores: Constantine E Kosmas, Andreas Sourlas, Gordon Mallarkey, Delia Silverio, Domingo Y Ynoa, Peter D Montan, Eliscer Guzman, Mario J Garcia
Formato: Artigo
Idioma:Inglês
Publicado em: BioExcel Publishing Ltd 2019-09-01
coleção:Drugs in Context
Assuntos:
cardiovascular disease
cardiovascular risk
hyperlipoproteinemia (a)
lipoprotein (a)
therapeutic management
Acesso em linha:https://www.drugsincontext.com/therapeutic-management-of-hyperlipoproteinemia-(a)/
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados